Paragraph 2 Interpretation

In these Rules—

• “Appeals Committee” means the Appeals Committee established under article 4(6)(c) of the Order;

• “CPD”—

  1. (a)

     means the continuing professional development which registrants are required to undertake in order to have an entry in the Register renewed and to maintain competence; and

  2. (b)

     includes—

     1. (i)

        any continuing professional development that relates to an annotation in respect of a specialisation made to a registrant's entry in the Register;

     2. (ii)

        any continuing professional development that a registrant is required to undertake by virtue of rules made under article 27(1) or 37(3)(c)(iii) of the Order;

• “CPD framework” means the framework relating to the CPD of registrants which is adopted by the Council under article 43(4)(a) of the Order;

• “CPD record”, in relation to a registrant, means a written record in hard copy form or electronic form which is completed by the registrant and in which details are entered by the registrant about the CPD that the registrant has undertaken since—

  1. (a)

     the date of completion of the immediately preceding review by the Registrar of the registrant's CPD; or

  2. (b)

     if no review has taken place since the date on which an entry in the Register relating to the registrant was made or restored, the date of that entry;

• “Fitness to Practise Committee” means the Fitness to Practise Committee established under article 4(6)(b) of the Order;

• “Fitness to Practise Rules” means the General Pharmaceutical Council (Fitness to Practise and Disqualification etc.) Rules 2010 M1;

• “Investigating Committee” means the Investigating Committee established under article 4(6)(a) of the Order;

• “remedial measure” means any requirement specified in rule 6(1)(a) to (h);

• “supplementary notice” means a notice under rule 8(5)(b) (and includes a notice under that provision as it applies by virtue of rule 8(6));

• “the Order” means the Pharmacy Order 2010.